In our opinion, the data reminds investors and practitioners that AI hype does not equal budget immunity. While earlier data documented robust intent to invest, the C-suite view presented above ...

Report Ocean has published a new report on the Saudi Arabia Sunflower Oil Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report ...

One unique aspect of the Saudi Arabian Automotive Engine Oils market is its alignment with the country’s growing automotive sector. Saudi Arabia is home to several automotive manufacturing and ...

Discover how the Virtus InfraCap U.S. Preferred Stock ETF leverages a unique strategy to generate income, hedge risks & ...

Novartis AG, a pharmaceutical powerhouse with a market capitalization of $214.57 billion, reported robust financial results for the first quarter of 2025, with net sales growing by 15% in constant ...

Alenglipron’s unique structural properties may lead to differentiated weight loss results in the upcoming ACCESS trials. The analyst noted that the drug’s clear safety and toxicity profile ...

And as capital becomes more politicized, inflation more entrenched, and traditional reserves more correlated, Bitcoin’s differentiated profile becomes not just defensible—but strategically necessary.

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-reports-fourth-quarter-and-full-year-2024-financial-results-and-recent ...

Many chart watchers view the 200-DMA as a dividing line between longer-term uptrends and downtrends. That line currently comes in at 5,730.87, according to FactSet, while the S&P 500 was recently ...

Job openings for software engineers on Indeed are at their lowest level in five years. Marc Benioff said Salesforce might not hire software engineers in 2025 because of gains from AI. Despite AI's ...

Norwegian classification society DNV has proposed a technology performance level (TPL) chart for perovskite PV modules. The chart features as part of DNV’s recently-released technical ...

Bradner insisted to analysts on this morning’s call that Amgen sees “a quite differentiated profile, really across all terms of efficacy, tolerability, dosing and patient experience” when it ...